A radiobiological model of reoxygenation and fractionation effects.

about

Radiobiological Optimization in Lung Stereotactic Body Radiation Therapy: Are We Ready to Apply Radiobiological Models?

P2860

Q47718099-87AB9997-5655-45C6-BE93-5B1A80CB5103

P2860

A radiobiological model of reoxygenation and fractionation effects.

Item

http://www.wikidata.org/entity/Q53453719

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

A radiobiological model of reoxygenation and fractionation effects.

@en

A radiobiological model of reoxygenation and fractionation effects.

@nl

type

Item

label

A radiobiological model of reoxygenation and fractionation effects.

@en

A radiobiological model of reoxygenation and fractionation effects.

@nl

prefLabel

A radiobiological model of reoxygenation and fractionation effects.

@en

A radiobiological model of reoxygenation and fractionation effects.

@nl

P1476

A radiobiological model of reoxygenation and fractionation effects.

@en

P2093

David J Carlson

http://www.w3.org/2001/XMLSchema#string

Mariana Guerrero

http://www.w3.org/2001/XMLSchema#string

P2860

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee.

Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters.

Optimization of the fractionated irradiation scheme considering physical doses to tumor and organ at risk based on dose-volume histograms.

Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia.

The dependence of optimal fractionation schemes on the spatial dose distribution.

PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients.

Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies.

From CHART to CHARTWEL in Non-small Cell Lung Cancer: Clinical Radiobiological Modelling of the Expected Change in Outcome

P304

2002-2010

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MP.12194

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28273349

http://www.w3.org/2001/XMLSchema#string

A radiobiological model of reoxygenation and fractionation effects.

about

P2860

P2860

A radiobiological model of reoxygenation and fractionation effects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698